JP2011137045A5 - - Google Patents

Download PDF

Info

Publication number
JP2011137045A5
JP2011137045A5 JP2011086840A JP2011086840A JP2011137045A5 JP 2011137045 A5 JP2011137045 A5 JP 2011137045A5 JP 2011086840 A JP2011086840 A JP 2011086840A JP 2011086840 A JP2011086840 A JP 2011086840A JP 2011137045 A5 JP2011137045 A5 JP 2011137045A5
Authority
JP
Japan
Prior art keywords
group
olefin
aromatic
acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011086840A
Other languages
English (en)
Japanese (ja)
Other versions
JP5629632B2 (ja
JP2011137045A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011137045A publication Critical patent/JP2011137045A/ja
Publication of JP2011137045A5 publication Critical patent/JP2011137045A5/ja
Application granted granted Critical
Publication of JP5629632B2 publication Critical patent/JP5629632B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011086840A 2003-09-25 2011-04-08 9,10−α,α−OH−タキサンアナログおよびその生成のための方法 Expired - Lifetime JP5629632B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25
US60/506,680 2003-09-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006528316A Division JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014141964A Division JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Publications (3)

Publication Number Publication Date
JP2011137045A JP2011137045A (ja) 2011-07-14
JP2011137045A5 true JP2011137045A5 (cg-RX-API-DMAC7.html) 2012-05-24
JP5629632B2 JP5629632B2 (ja) 2014-11-26

Family

ID=34393186

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2006528316A Expired - Lifetime JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2010200399A Expired - Lifetime JP5525394B2 (ja) 2003-09-25 2010-09-07 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2011086840A Expired - Lifetime JP5629632B2 (ja) 2003-09-25 2011-04-08 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2014141964A Expired - Lifetime JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2016137271A Expired - Lifetime JP6216417B2 (ja) 2003-09-25 2016-07-12 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006528316A Expired - Lifetime JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2010200399A Expired - Lifetime JP5525394B2 (ja) 2003-09-25 2010-09-07 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014141964A Expired - Lifetime JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2016137271A Expired - Lifetime JP6216417B2 (ja) 2003-09-25 2016-07-12 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Country Status (14)

Country Link
US (8) US7745650B2 (cg-RX-API-DMAC7.html)
EP (2) EP1664033B1 (cg-RX-API-DMAC7.html)
JP (5) JP4874102B2 (cg-RX-API-DMAC7.html)
CN (1) CN1886400A (cg-RX-API-DMAC7.html)
AT (1) ATE377593T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004275881A1 (cg-RX-API-DMAC7.html)
CA (1) CA2539975C (cg-RX-API-DMAC7.html)
DE (1) DE602004009943T2 (cg-RX-API-DMAC7.html)
DK (1) DK1664033T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295937T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080057T3 (cg-RX-API-DMAC7.html)
PL (1) PL1664033T3 (cg-RX-API-DMAC7.html)
PT (1) PT1664033E (cg-RX-API-DMAC7.html)
WO (1) WO2005030150A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2539975C (en) 2003-09-25 2012-11-20 Tapestry Pharmaceuticals, Inc. 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
EP1973892A1 (en) * 2005-12-21 2008-10-01 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
MX2008008119A (es) * 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
CA2647766A1 (en) * 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
EP2029563A4 (en) * 2006-06-12 2009-12-02 Canada Inc 6570763 HALF-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) * 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
WO2013106029A1 (en) * 2011-04-07 2013-07-18 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
EP2717699B1 (en) * 2011-06-06 2020-06-03 Veiled Therapeutics LLC Acid-labile lipophilic prodrugs of chemo-therapeutic anti-cancer agents
TW202145975A (zh) 2020-03-04 2021-12-16 美商艾奎登生醫股份有限公司 具有伸縮護套的血管及主動脈連接器及其置放方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
ES2134847T3 (es) 1992-04-17 1999-10-16 Abbott Lab Derivados de taxol.
FR2697019B1 (fr) 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
ES2206465T3 (es) * 1992-11-13 2004-05-16 Florida State University Taxanos sustituidos con butenilo y composiciones farmaceuticas.
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
US6066747A (en) 1993-03-05 2000-05-23 Florida State University Process for the preparation of 9-desoxotaxanes
ATE218858T1 (de) * 1993-03-05 2002-06-15 Univ Florida State C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen
DK0690867T3 (da) * 1993-03-22 2003-06-10 Univ Florida State Taxaner med furyl- eller thienylsubstitueret sidekæde
FR2707293A1 (fr) 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
BR0104350A (pt) * 2000-02-02 2002-01-02 Univ Florida State Res Found Taxanos de c10 acetato heterossubstituìdo como agentes antitumor
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
AU2002254400B2 (en) 2001-03-23 2007-08-09 Napro Biotherapeutics, Inc. Molecular conjugates for use in treatment of cancer
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
RS52904A (sr) 2001-12-20 2006-12-15 Bristol-Myers Squib Company Farmaceutske smeše oralno aktivnih derivata taksana koje imaju povećanu bioraspoloživost
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
CA2539975C (en) * 2003-09-25 2012-11-20 Tapestry Pharmaceuticals, Inc. 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
EP1810968A3 (en) 2003-09-25 2007-08-08 Tapestry Pharmaceuticals, Inc. 9, 10-a, a-OH-taxane analogs and methods for production thereof
KR20080030564A (ko) 2005-05-12 2008-04-04 태피스트리 파마슈티컬스 인코퍼레이티드 표적 컨쥬게이트에 적합한 분자 구조물
MX2008008119A (es) 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
EP1973892A1 (en) 2005-12-21 2008-10-01 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
CA2647766A1 (en) 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Similar Documents

Publication Publication Date Title
JP2011137045A5 (cg-RX-API-DMAC7.html)
JP2015537008A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2017222697A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2014526533A5 (cg-RX-API-DMAC7.html)
JP2012144574A5 (cg-RX-API-DMAC7.html)
JP2010095546A5 (cg-RX-API-DMAC7.html)
JP2011105738A5 (cg-RX-API-DMAC7.html)
JP2013523975A5 (cg-RX-API-DMAC7.html)
JP2007506792A5 (cg-RX-API-DMAC7.html)
JP2011518833A5 (cg-RX-API-DMAC7.html)
JP2013508347A5 (cg-RX-API-DMAC7.html)
JP2013546173A5 (cg-RX-API-DMAC7.html)
JP2016503797A5 (cg-RX-API-DMAC7.html)
JP2015042636A5 (ja) 有機化合物
JP2015522045A5 (cg-RX-API-DMAC7.html)
JP2016505614A5 (cg-RX-API-DMAC7.html)
JP2013543842A5 (cg-RX-API-DMAC7.html)
JP2016525130A5 (cg-RX-API-DMAC7.html)
JP2012012417A5 (cg-RX-API-DMAC7.html)
JP2015199738A5 (cg-RX-API-DMAC7.html)
JP2012094862A5 (cg-RX-API-DMAC7.html)
JP2016503403A5 (cg-RX-API-DMAC7.html)
JP2015514781A5 (cg-RX-API-DMAC7.html)